Keego Harbor, Michigan – Health Enhancement Products Inc. announces a credit facility increase to $6 million to fund bovine and canine validation studies.
Health Enhancement Products, Inc.
The Health Enhancement Products, Incorporated (HEPI) is a Michigan-based innovative biotech firm. Recently, its primary lender has increased the credit facility to $6 million for the said company. The $1 million is made available immediately in expediting both bovine and canine validation studies. These studies are ongoing in Canada and the United States simultaneously.
Expansion of Programs
Andrew Dahl, the President and Chief Executive Officer (CEO) of the company says that the increase in the company’s credit will allow them in expediting and broadening their set of studies. The CEO adds that the increase in funds also allows a potential transition from research to licensing discussion. The latest investment on bovine and canine validation studies, and inquiries from capital investors are viewed as “vote of confidence” towards the company’s process and prospects, Dahl emphasizes.
Bovine Pilot Program
The Bovine Pilot program is a research and validation effort focusing on the immune response in treating bovine mastitis, which is a condition that affects the production of milk. The said condition may require expert services from urgent care clinics. Moreover, this condition affects American dairy producers, losing about $3 billion annually. Considered as a global problem, bovine mastitis affects 10% of the globe’s 244 million cows. The condition needs an urgent care and immediate attention.
Canine Study
On the other hand, the canine study will be expanded. The company is planning to include refined samples as well as a direct challenge model. The inclusions will allow further studies on the company’s bioactive compounds against chondroitin and glucosamine. These are the most common and active ingredients found in canine joint health supplements. As an urgent care clinic and a cost-effective product to dog owners, the company is working on a viable alternative that will be beneficial to the canine’s immune system response.
Human and Animal Applications
The company’s main goal is to investigate the health benefits of bioactive compounds. It is also geared towards developing natural bioactive compounds that can be used in food ingredients and dietary supplements. Aside from an urgent care near me facility, consumers also need a certain entity that would continue studying applications for both humans and animals. Nonetheless, HEPI continues to study potential candidates that focus on the autoimmune modulation for both pharmaceutical and medical future applications. The bovine and canine validation studies are major transitions for the company’s further developments.